Xenon Pharmaceuticals Inc

XENENASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
54.22 USD
↗ 0.54 (0.99%)🟢PRE MARKET (AS OF 04:02 AM EDT)
🟢Market: OPEN
Open?$54.27
High?$54.80
Low?$54.27
Prev. Close?$54.26
Volume?3
Avg. Volume?1.1M
VWAP?$54.27
Rel. Volume?0.00x
Bid / Ask
Bid?$46.94 × 100
Ask?$61.71 × 100
Spread?$14.77
Midpoint?$54.33
Valuation & Ratios
Market Cap?5.2B
Shares Out?96.6M
Float?68.7M
Float %?88.9%
P/E Ratio?N/A
P/B Ratio?9.01
EPS?-$3.58
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.42Strong
Quick Ratio?13.42Strong
Cash Ratio?4.77Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A▾
P/B?
9.01HIGH▾
P/S?
699.18HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-13.6CHEAP▾
EV/Sales?
672.62HIGH▾
Returns & Efficiency
ROE?
-59.5%WEAK▾
ROA?
-54.6%WEAK▾
Cash Flow & Enterprise
FCF?$-279917000
Enterprise Value?$5.0B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
5.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xenon-pharma.com
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
MarketsMoversWatchlist